pre-IPO PHARMA

COMPANY OVERVIEW

Avelas Biosciences aims to use its proprietary platform technology of activatable cell-penetrating peptides (ACPPs) for both surgical and therapeutic applications to create better outcomes for cancer patients.


LOCATION

  • La Jolla, CA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.avelasbio.com/


    CAREER WEBSITE

    https://www.avelasbio.com/careers/


    SOCIAL MEDIA


    INVESTORS

    alexandria-venture-investments avalon-ventures bregua-corporation ervington-investments torrey-pines-investment wuxi-healthcare-ventures


    PRESS RELEASES


    Sep 26, 2018

    Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference


    Aug 2, 2018

    Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery


    Jun 14, 2018

    Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference


    Mar 21, 2018

    Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference


    Jan 4, 2018

    Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery


    For More Press Releases


    Google Analytics Alternative